Lazard Asset Management LLC Arvinas, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,031 shares of ARVN stock, worth $68,773. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,031
Previous 3,586
15.48%
Holding current value
$68,773
Previous $95,000
22.11%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$159 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$153 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$142 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$87.4 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$63.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.21B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...